Several Substances Get Placed on the Category 2 Bulks List The following substances were added to Category 2 because FDA claimed to identify significant safety risks: AOD 9604 BPC-157 Cathelicidin LL-37 CJC-1295 Dihexa Acetate Emideltide (DSIP) Epitalon GHK-Cu (for injectable routes of administration) Ibutamoren Mesylate Ipamorelin Acetate Kisspeptin-10 KPV Melanotan II Mechano Growth Factor, Pegylated (PEG-MGF) MOTs-C Selank Acetate (TP-7) Semax (heptapeptide) Thymosin Alpha-1 (Ta1) Thymosin Beta-4, Fragment (LKKTETQ) Compounding Industry Group Initial Response In early October, Scott Brunner from the Alliance for Pharmacy Compounding (APC) commented on the updates, particularly noting the addition of certain peptides to Category 2

Previous studies have shown that infusion of recombinant human IGF-1 to the sheep fetus for 3 hours yielded small (6%) but statistically significant increases in fetal plasma concentrations of IGFBP-1, IGFBP-2, and IGFBP-3 despite large (74%) increases in IGF-1 concentrations ( IGFBP-1 also increased with infusion of recombinant human IGF-1 in the setting of normal fetal insulin and nutrient concentrations, but expression of IGFBP-3 did not change ( IGFBPs 13 in the liver and skeletal muscle
When it comes to achieving a radiant, even-toned complexion, many people turn to skin whitening creams as a solution
Not everyone needs every peptide, and staggered implementation helps identify the minimum effective stack
Reduction in signs of aging like fine lines and wrinkles
Provider guidance based on your health status is essential